The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for February 2009 (PDF).
This issue contains yellow card reporting guidance, pointers on where to access the latest safety information online and drug safety advice in the following areas:
- Tibolone (Livial): increased risk of breast cancer recurrence
- Non-steroidal anti-inflammatory drugs: cardiovascular risk
Action: Clinicians will find this publication to be a useful review of current issues in drug safety.
|« February CKS Update||HRT and breast cancer risk »|